Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer's disease mortality in older adults

Dementia and Geriatric Cognitive Disorders

Volumn 37, Issue 3-4, 2014, Pages 246-256

  Min, Jin Young ^a   Min, Kyoung Bok ^b  

^a Seoul National University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Carotenoid; Oxidative stress; Prevention

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; BETA CRYPTOXANTHIN; BIOLOGICAL MARKER; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN; ANTIOXIDANT; CAROTENOID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SMOKING; UNITED STATES; VITAMIN BLOOD LEVEL; AGE; CAUCASIAN; EDUCATIONAL STATUS; FOLIC ACID BLOOD LEVEL; GERIATRIC PATIENT; MIDDLE AGED; VERY ELDERLY; BLOOD; KAPLAN MEIER METHOD; METABOLISM; MULTIVARIATE ANALYSIS; NUTRITION; OXIDATIVE STRESS; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; CAROTENOIDS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUTEIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; OXIDATIVE STRESS; RISK FACTORS; RISK REDUCTION BEHAVIOR; ZEAXANTHINS;

EID: 84899840300     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000356486     Document Type: Article

References (45)

1. Maurer K, Maurer U: Alzheimer: The Life of a Physician and Career of a Disease. New York, Columbia University Press, 2003.
2. Markesbery WR: The role of oxidative stress in Alzheimer disease. Arch Neurol 1999; 56: 1449-1452.
3. Markesbery WR, Lovell MA: Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol 2007; 64: 954-956.
4. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM: Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287: 3223-3229.
5. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA: Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287: 3230-3237.
6. Devore EE, Grodstein F, van Rooij FJ, Hofman A, Stampfer MJ, Witteman JC, Breteler MM: Dietary antioxidants and long-term risk of dementia. Arch Neurol 2010; 67: 819-825.
7. Stahl W, Sies H: Antioxidant activity of carotenoids. Mol Aspects Med 2003; 24: 345-351.
8. Krinsky NI, Johnson EJ: Carotenoid actions and their relation to health and disease. Mol Aspects Med 2005; 26: 459-516.
9. De Waart FG, Schouten EG, Stalenhoef AF, Kok FJ: Serum carotenoids, alpha-tocopherol and mortality risk in a prospective study among Dutch elderly. Int J Epidemiol 2001; 30: 136-143.
10. Shardell MD, Alley DE, Hicks GE, El-Kamary SS, Miller RR, Semba RD, Ferrucci L: Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey. Nutr Res 2011; 31: 178-189.
11. Voutilainen S, Nurmi T, Mursu J, Rissanen TH: Carotenoids and cardiovascular health. Am J Clin Nutr 2006; 83: 1265-1271.
12. Riccioni G, D'Orazio N, Salvatore C, Franceschelli S, Pesce M, Speranza L: Carotenoids and vitamins C and E in the prevention of cardiovascular disease. Int J Vitam Nutr Res 2012; 82: 15-26.
13. Nishino H, Murakosh M, Ii T, Takemura M, Kuchide M, Kanazawa M, Mou XY, Wada S: Carotenoids in cancer chemoprevention. Cancer Metastasis Rev 2002; 21: 257-264.
14. Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, Hallmans G, Helzlsouer KJ, Hoffman-Bolton J, Hulten K, Sesso HD, Sowell AL, Tamimi RM, Toniolo P, Wilkens LR, Winkvist A, Zeleniuch-Jacquotte A, Zheng W, Hankinson SE: Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 2012; 104: 1905-1916.
15. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P: Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 2000; 31: 2301-2306.
16. Hozawa A, Jacobs DR Jr, Steffes MW, Gross MD, Steffen LM, Lee DH: Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. Clin Chem 2007; 53: 447-455.
17. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449-1455.
18. Rubin DB: Multiple Imputation for Nonresponse in Surveys. New York, Wiley, 1987.
19. Schafer JL: Analysis of Incomplete Multivariate Data. New York, Chapman & Hall, 1997.
20. Campbell DR, Gross MD, Martini MC, Grandits GA, Slavin JL, Potter JD: Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev 1994; 3: 493-500.
21. Gunter EW, Lewis BL, Koncikowski SM: Laboratory methods used for the Third National Health and Nutrition-Examination Survey (NHANES III), 1988-1994. Atlanta, US Department of Health and Human Services, 1996.
22. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM: Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001; 49: 1-32.
23. Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT: Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. QJM 1999; 92: 39-45.
24. Jimenez-Jimenez FJ, Molina JA, de Bustos F, Orti-Pareja M, Benito-Leon J, Tallon-Barranco A, Gasalla T, Porta J, Arenas J: Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease. Eur J Neurol 1999; 6: 495-497.
25. Mecocci P, Polidori MC, Cherubini A, Ingegni T, Mattioli P, Catani M, Rinaldi P, Cecchetti R, Stahl W, Senin U, Beal MF: Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 2002; 59: 794-798.
26. Polidori MC, Mecocci P: Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis 2002; 4: 517-522.
27. Polidori MC, Mattioli P, Aldred S, Cecchetti R, Stahl W, Griffiths H, Senin U, Sies H, Mecocci P: Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 2004; 18: 265-270.
28. Wang W, Shinto L, Connor WE, Quinn JF: Nutritional biomarkers in Alzheimer's disease: the association between carotenoids, n-3 fatty acids, and dementia severity. J Alzheimers Dis 2008; 13: 31-38.
29. Stahl W, Sies H: Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 1996; 336: 1-9.
30. Yeum KJ, Russell RM: Carotenoid bioavailability and bioconversion. Annu Rev Nutr 2002; 22: 483-504.
31. Grusak MA, DellaPenna D: Improving the nutrient composition of plants to enhance human nutrition and health 1. Annu Rev Plant Physiol Plant Mol Biol 1999; 50: 133-161.
32. Mortensen A, Skibsted LH, Truscott TG: The interaction of dietary carotenoids with radical species. Arch Biochem Biophys 2001; 385: 13-19.
33. Rao AV, Rao LG: Carotenoids and human health. Pharmacol Res 2007; 55: 207-216.
34. Di Mascio P, Kaiser S, Sies H: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274: 532-538.
35. Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, Kim HS, Christov-Tzelkov K, van Breemen R: Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med (Maywood) 2002; 227: 886-893.
36. Heber D, Lu QY: Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 2002; 227: 920-923.
37. Aust O, Ale-Agha N, Zhang L, Wollersen H, Sies H, Stahl W: Lycopene oxidation product enhances gap junctional communication. Food Chem Toxicol 2003; 41: 1399-1407.
38. Zaripheh S, Nara TY, Nakamura MT, Erdman JW Jr: Dietary lycopene downregulates carotenoid 15,15 ′-monooxygenase and PPAR-gamma in selected rat tissues. J Nutr 2006; 136: 932-938.
39. Krinsky NI, Landrum JT, Bone RA: Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003; 23: 171-201.
40. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P: Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003; 24: 915-919.
41. Akbaraly NT, Faure H, Gourlet V, Favier A, Berr C: Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA Study. J Gerontol A Biol Sci Med Sci 2007; 62: 308-316.
42. Polidori MC, Pratico D, Mangialasche F, Mariani E, Aust O, Anlasik T, Mang N, Pientka L, Stahl W, Sies H, Mecocci P, Nelles G: High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J Alzheimers Dis 2009; 17: 921-927.
43. Haegele AD, Gillette C, O'Neill C, Wolfe P, Heimendinger J, Sedlacek S, Thompson HJ: Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiol Biomarkers Prev 2000; 9: 421-425.
44. Torbergsen AC, Collins AR: Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr 2000; 39: 80-85.
45. Astley SB, Elliott RM, Archer DB, Southon S: Increased cellular carotenoid levels reduce the persistence of DNA single-strand breaks after oxidative challenge. Nutr Cancer 2002; 43: 202-213.